Figure 2 Male observed survival of the entire cohort versus expected survival based on aggregate mortality statistics of all participating countries. Male expected versus observed survival rates were 99.6% versus 98.9%, 96.2% versus 91.8%, and 91.2% versus 87.5%, one, five, and 10 years after diagnosis, respectively. No, number of patients.